Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized Chemotherapy Based on BRCA1 and RRM1 in Advanced NSCLC
NCT01424709Phase 2Unknown
- Sponsor
- Tongji University
- Start
- Dec 2010
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, cisplatin, docetaxel, irinotecan in non-small cell lung cancer (NSCLC), sponsored by Tongji University. Status: unknown.
02
Drugs
gemcitabinecisplatindocetaxelirinotecan
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01424709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01424709.